TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 01, 2021
- Source ID
- 10.1016/j.cell.2021.03.051
Entities
People
- Adolfo García-Sastre
- Alba Escalera
- Anand D. Jeyasekharan
- Andre L. Moreira
- Andrew C Y Lee
- Anna Junxia Zhang
- Benjamin R tenOever
- Betsaida Salom Melo
- Bobo Wing-yee Mok
- Chris Benner
- David A. Kaufman
- David A. Meekins
- Elaine Shum
- Emily R. Miraldi
- Ernesto Guccione
- Helen Ray-jones
- Honglian Liu
- Honglin Chen
- Igor Morozov
- Ivan Marazzi
- Jan Bakker
- Jessica Sook Yuin Ho
- Jessie D. Trujillo
- Joseph A. Wayman
- Juergen A. Richt
- Kris M White
- Laura Campisi
- Mariano Carossino
- Matthew T Weirauch
- Michael Schotsaert
- Michiel J. Thiecke
- Mikhail Spivakov
- Minji Byun
- Nan Zhao
- Natasha N. Gaudreault
- Randy A. Albrecht
- Raveen Rathnasinghe
- Robert Sebra
- Sabarish V. Indran
- Simin Zheng
- Siu-ying Lau
- Soner Yildiz
- Sonia Jangra
- Sreeja Parameswaran
- Sumit K Chanda
- Sven Heinz
- Teresa Allende Aydillo Gomez
- Tristan X Jordan
- Udeni B.r. Balasuriya
- Valeriya Malysheva
- Wen-chun Liu
- Yesai S. Fstkchyan
- Zeyu Zhu
Organizations
- Burroughs Wellcome Fund
- Defense Advanced Research Projects Agency
- Freedom Together Foundation
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Swiss National Science Foundation
- United States Department of Defense
- United States Department of Homeland Security